JCR Pharmaceuticals Co.,Ltd. FY2026 Q3 Earnings Report | IR Tracker

JCR Pharmaceuticals Co.,Ltd. FY2026 Q3 Earnings Report | IR Tracker

Quick View

Metric	Current	Prior	YoY
Revenue	¥303.5B	¥258.8B	+17.3%
Operating Income	¥4.3B	¥-7.5B	+156.6%
Ordinary Income	¥7.1B	¥-13.8B	+151.5%
Net Income	¥18.0B	¥-4.8B	+475.7%
ROE	3.8%	-1.0%	-

Executive Summary

Performance Drivers

Segment Analysis

Key Metrics

Cash Flow Analysis

Earnings Quality

Guidance Update

Shareholder Returns

Catalysts

Industry Benchmark (Reference - Proprietary Data)

Risk Factors

Key Takeaways from Earnings

**